Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vulvar dystrophies: an evaluation.

A Ayhan1, K Yüce, B Urman

  • 1Department of Obstetrics and Gynaecology, University of Hacettepe, Faculty of Medicine, Ankara, Turkey.

The Australian & New Zealand Journal of Obstetrics & Gynaecology
|August 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproductive surgery remains an essential element of reproductive medicine.

Facts, views & vision in ObGyn·2024
Same author

Correction to: The HERA (Hyper‑response Risk Assessment) Delphi consensus for the management of hyper‑responders in in vitro fertilization.

Journal of assisted reproduction and genetics·2023
Same author

The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilization.

Journal of assisted reproduction and genetics·2023
Same author

The HERA (Hyper-response Risk Assessment) Delphi consensus definition of hyper-responders for in-vitro fertilization.

Journal of assisted reproduction and genetics·2023
Same author

Adhesions and Anti-Adhesion Systems Highlights.

Facts, views & vision in ObGyn·2019
Same author

Platelet function testing: dead or alive.

Journal of thrombosis and haemostasis : JTH·2018
Same journal

Obstetric Management and Outcomes for Women Living With HIV in Western Australia: A 30 Year Review.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Determining the Feasibility of a No-Ultrasound Screening Tool for Early Medical Abortion in Australia.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

'All In': Equitable Health Outcomes Require Culturally Safe Care for Everybody.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Benzylpenicillin Concentrations in Intrapartum Group B Streptococcus Prevention Guidelines; A Systematic Review of the Evidence.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Retrospective Cohort Study of Foetal Growth Restricted Births After 40 Weeks at an Australian Tertiary Maternity Hospital Between 2018 and 2021.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
Same journal

Models of Antenatal Care for Rural Indigenous Women: A Systematic Review.

The Australian & New Zealand journal of obstetrics & gynaecology·2026
See all related articles

This study on vulvar dystrophy found high treatment response rates for hyperplastic, lichen sclerosus, and mixed types using corticosteroids and testosterone. Surgery was a last resort for persistent cases.

Area of Science:

  • Dermatology
  • Gynecology
  • Pathology

Background:

  • Vulvar dystrophy encompasses several conditions affecting vulvar skin.
  • Accurate diagnosis is crucial for effective management.
  • Treatment strategies vary based on dystrophy subtype.

Purpose of the Study:

  • To evaluate treatment outcomes for different types of vulvar dystrophy.
  • To assess the efficacy of medical therapies and the role of surgery.

Main Methods:

  • Retrospective analysis of 86 patients diagnosed with vulvar dystrophy over 10 years.
  • Diagnosis confirmed via colposcopic or toluidine blue-directed biopsies.
  • Treatment included fluorinated corticosteroids, topical testosterone propionate, or combination therapy.

Related Experiment Videos

Main Results:

  • Hyperplastic dystrophy (65.1%) showed a 90.1% response to corticosteroids.
  • Lichen sclerosus (26.7%) had an 87.7% response to testosterone propionate.
  • Mixed dystrophy (7.2%) achieved an 85.8% response with combination therapy.

Conclusions:

  • Medical management with corticosteroids and testosterone propionate is highly effective for vulvar dystrophy subtypes.
  • Surgical intervention is reserved for medically refractory cases.
  • These findings support a stepwise therapeutic approach for vulvar dystrophy.